SKI Market

Indian Indices

Sensex

79,698.92 -316.98
( -0.40%)

Global Indices

Nasdaq

47,963.68 -796.74
(-1.63%)

Dow Jones

6,850.98 -39.52
(-0.57%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,430.91 -136.74
(-1.29%)

Forex

USD-INR

92.13 0.17
(0.19%)

EUR-INR

107.06 0.12
(0.11%)

GBP-INR

123.03 0.33
(0.27%)

JPY-INR

0.59 0.00
(0.39%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.12

2785.85

EPS(TTM)

Face Value()

Div & Yield %

5.04

0.04

Back

kay power & paper ltd

Endurance Technologies consolidated net profit rises 20.20% in the December 2025 quarter

Feb 13,2026

Net profit of Endurance Technologies rose 20.20% to Rs 221.64 crore in the quarter ended December 2025 as against Rs 184.39 crore during the previous quarter ended December 2024. Sales rose 26.20% to Rs 3608.22 crore in the quarter ended December 2025 as against Rs 2859.16 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3608.22	2859.16	26
OPM %	13.22	13.03	-
PBDT	499.53	382.98	30
PBT	321.62	246.59	30
NP	221.64	184.39	20

79,698.92 -316.98 ( -0.40%)

47,963.68 -796.74 (-1.63%)

6,850.98 -39.52 (-0.57%)

55,141.42 895.88 (1.65%)

10,430.91 -136.74 (-1.29%)

92.13 0.17 (0.19%)

107.06 0.12 (0.11%)

123.03 0.33 (0.27%)

0.59 0.00 (0.39%)